RECRUITING

A Comparison of Neuromuscular Recruitment in Trained and Untrained Adults

Talk to us

Conditions

HealthyInsulin Resistanceneuromusculartranscranial magnetic stimulation

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The objective of the study is to use neurological techniques to obtain quantitative measurements of nervous system control of skeletal muscle activity in adults aged 60-85 who are either long-term resistance exercisers or who are untrained.

Official Title

A Comparison of Neuromuscular Recruitment in Trained and Untrained Adults

Quick Facts

Study Start:2025-02-26
Study Completion:2028-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06820658

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:60 Years to 85 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. * Surgical History - Gastric surgery, pacemaker placement, weight loss surgery, metabolic and obstetric surgery.
  2. * Smokers will be excluded from the study.
  3. * Medications: Insulins, common diabetic drugs, anti-hyperglycemic drugs, beta blockers cardiac selective, beta-blockers noncardiac selective, oral steroids, opioids anti-depressants, and hormones
  4. * Conidiations and Diagnosis: Disorder of coronary artery, hepatic failure, gastroparesis, disorder of the adrenal gland, drug related disorders, substance abuse, malignant neoplastic disease, psychotic disorders, disorder of skeletal muscle, finding of brain, chronic kidney disease, renal failure syndrome, disorder of pulmonary circulation, cerebrovascular disease, neuro developmental disorder, disorder of immune function, disorder of central nervous system.
  5. * Participants are not to have an abnormal value as part of a lipid panel within the past 6 months.
  6. * Participant will be excluded if they have recreational drug use or a history of alcohol abuse
  7. * Inability or unwillingness of individual or legal guardian/representative to give written informed consent.
  8. * Current or past participation within a specified timeframe in another clinical trial, as warranted by the administration of this intervention.
  9. * Participant will be excluded if they have epilepsy.
  10. * Participant will be excluded if they have cranial metal/device implants
  11. * Participant will be excluded if they are pregnant

Contacts and Locations

Study Contact

Rose Decker
CONTACT
507-255-6670
Bilderback.Rose@mayo.edu

Principal Investigator

K. S. Nair, M.D., Ph.D.
PRINCIPAL_INVESTIGATOR
Mayo Clinic

Study Locations (Sites)

Mayo Clinic
Rochester, Minnesota, 55905
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • K. S. Nair, M.D., Ph.D., PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-02-26
Study Completion Date2028-10

Study Record Updates

Study Start Date2025-02-26
Study Completion Date2028-10

Terms related to this study

Keywords Provided by Researchers

  • neuromuscular
  • transcranial magnetic stimulation

Additional Relevant MeSH Terms

  • Healthy
  • Insulin Resistance